journal article·2018-11-12Open access

In vitro and in vivo investigation of the novel Dex-bHb as oxygen carriers

Jun Zhang, Ying Wang, Shan Zhang, Guo-Xing You, Peng-Long Li, Quan Wang, Wei-Li Yu, Tao Hu, Hong Zhou, Lian Zhao

Abstract

The development of hemoglobin-based oxygen carriers (HBOCs) is a persistent and urgent need in biomedicine. As a potential HBOCs, Dextran-hemoglobin (Dex-bHb) has been developed over the past years. The novel Dex-bHb, whose thiol group of Cys-93(β) was reversibly protected, was produced and the characteristics were evaluated in our previous study. Herein, blood compatibility was characterized in terms of the red blood cell aggregation and hemolysis rate in vitro, and Dex-bHb showed no obvious effects. After intravenous administration of Dex-bHb to golden Syrian hamsters with hemorrhages shock, it showed mean arterial pressure recovery, blood flow increase and the organ protection from serious hemorrhage injury. Consequently, Dex-bHb is hopeful to be a safe and available blood substitute.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Hemoglobin structure and function · Heme Oxygenase-1 and Carbon Monoxide · Erythrocyte Function and Pathophysiology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Health Service and Transfusion Medicine, Academy of Military Medical Sciences

State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences

Funding

National Natural Science Foundation of China

References (27)

Show source-provided references
1. 10.1016/j.tibtech.2006.06.00510.1016/j.tibtech.2006.06.005 ↗
2. Seifried E, Mueller MM. The present and future of transfusion medicine. Blood Transfus. 2011;9:371.
3. 10.1213/ANE.0b013e3181cd473b10.1213/ANE.0b013e3181cd473b ↗
4. 10.1016/j.tibtech.2014.02.00610.1016/j.tibtech.2014.02.006 ↗
5. 10.1001/jama.299.19.jrv8000710.1001/jama.299.19.jrv80007 ↗
6. 10.1080/21691401.2017.137118410.1080/21691401.2017.1371184 ↗
7. 10.1016/j.procbio.2017.05.02110.1016/j.procbio.2017.05.021 ↗
8. 10.1073/pnas.73.6.212810.1073/pnas.73.6.2128 ↗
9. 10.1139/o78-15310.1139/o78-153 ↗
10. 10.1042/bj193026110.1042/bj1930261 ↗
11. 10.3109/1073119940911788210.3109/10731199409117882 ↗
12. 10.1007/BF0198569410.1007/BF01985694 ↗
13. Manjula BN, Acharya SA. Purification and molecular analysis of hemoglobin by high-performance liquid chromatography. Meth Mol Med. 2003;82:31–47.
14. 10.1002/app.2296110.1002/app.22961 ↗
15. 10.1016/j.colsurfb.2015.12.01210.1016/j.colsurfb.2015.12.012 ↗
16. 10.1021/nl080561510.1021/nl0805615 ↗
17. 10.1161/01.CIR.97.6.56210.1161/01.CIR.97.6.562 ↗
18. 10.1007/s00134-002-1558-110.1007/s00134-002-1558-1 ↗
19. 10.1007/s10517-017-3640-210.1007/s10517-017-3640-2 ↗
20. Luo Z, Wang P, Zhang A, et al. Evaluation of the microcirculation in a rabbit hemorrhagic shock model using laser Doppler imaging. PloS One. 2015;10:e0116076.10.1371/journal.pone.0116076 ↗
21. 10.1186/cc285110.1186/cc2851 ↗
22. 10.1097/00000542-197408000-0000610.1097/00000542-197408000-00006 ↗
23. 10.1186/1471-2091-12-6610.1186/1471-2091-12-66 ↗
24. 10.1016/j.resuscitation.2008.01.00810.1016/j.resuscitation.2008.01.008 ↗
25. Cabrales P, Intaglietta M, Tsai AG. Increase plasma viscosity sustains microcirculation after resuscitation from hemorrhagic shock and continuous bleeding. Shock. 2005;23:549–555.
26. 10.1093/toxsci/kfs10910.1093/toxsci/kfs109 ↗
27. 10.1111/j.1525-1594.1997.tb00250.x10.1111/j.1525-1594.1997.tb00250.x ↗